Adiposity-independent sympathetic activity in black men

Journal of Applied Physiology

Volumn 108, Issue 6, 2010, Pages 1613-1618

  Abbas, Aamer ^a   Szczepaniak, Lidia S ^a   Tuncel, Meryem ^a   McGavock, Jonathan M ^a   Huet, Beverley ^a   Fadel, Paul J ^a   Wang, Zhongyun ^a   Arbique, Debbie ^a   Victor, Ronald ^a   Vongpatanasin, Wanpen ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Baroreceptor; Blacks; Insulin; Obesity; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ADULT; ARTICLE; FEMALE; HUMAN; MALE; NEGRO; OBESITY; PATHOPHYSIOLOGY; SEX DIFFERENCE; BLACK PERSON;

ADIPOSITY; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; OBESITY; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 77953161942     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00058.2010     Document Type: Article

References (31)

1. Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, Howell-Stampley T, Vongpatanasin W, Victor RG. Overweight and sympathetic overactivity in Black Americans. Hypertension 38: 379-383, 2001.
2. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 287: H414-H418, 2004.
3. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 106: 2533-2536, 2002.
4. American Heart Association. Heart and Stroke Statistics-2009 Update. Dallas, TX: American Heart Association, 2009.
5. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252, 1991.
6. Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 118: 867-882, 1993. (Pubitemid 23145412)
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
8. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Maneia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97: 2037-2042, 1998. (Pubitemid 28243666)
9. Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, Maneia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49: 535-541, 2007. (Pubitemid 46263238)
10. Grassi G, Seravelle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Maneia G. Sympathetic activation in obese normotensive subjects. Hypertension 25: 560-563, 1995.
11. Gudbjornsdottir S, Lonnroth P, Sverrisdottir YB, Wallin BG, Elam M. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 27: 276-280, 1996.
12. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270-278, 1997. (Pubitemid 27349073)
13. Karason K, Melgaard H, Wikstrand J, Sjöström L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 83: 1242-1247, 1999.
14. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension 19, Suppl 1:1-61, 1992.
15. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 15: 216-224, 2007. (Pubitemid 46219802)
16. Mark AL. Weight reduction for treatment of obesity-associated hypertension: nuances and challenges. Curr Hypertens Rep 9: 368-372, 2007.
17. Masuo K, Mikami H, Ogihara T, Tuck ML. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 32: 96-100, 1998.
18. Masuo K, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42: 474-480, 2003. (Pubitemid 37237341)
19. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 10: 77-83, 1997. (Pubitemid 27038975)
20. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98: 772-776, 1998. (Pubitemid 28391842)
21. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 19992004. JAMA 295: 1549-1555, 2006.
22. Scherrer U, Owlya R, Trueb L. Sympathetic-nerve activity before and after resection of an insulinoma. N Engl J Med 335: 1240-1242, 1996.
23. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634-2640, 1994. (Pubitemid 24173681)
24. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 31: 409-414, 1998. (Pubitemid 28124750)
25. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni L Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49: 27-33, 2007. (Pubitemid 46360337)
26. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17: 669-677, 1991.
27. Vallbo AB, Hagbarth KE, Toreebjork HE, Wallin BG. Somatosensory proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919-957, 1979.
28. Vaz M, Jennings G, Turner A, Cox H, Lambert G, ME. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96: 3423-3429, 1997. (Pubitemid 27513415)
29. Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 36: 531-537, 2000.
30. Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med 55: 230-236, 2007. (Pubitemid 47555941)
31. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto EA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cateliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105: 1354-1359, 2002. (Pubitemid 34260428)